Signal Diagnostics agrees to pay $20.5M to settle COVID-19 testing overpayment claims
News
Archived
•
October 1, 2026
•
Signal Diagnostics LLC has agreed to pay the United States $20.5 million to resolve allegations that it violated the False Claims Act by knowingly retaining federal overpayments and improperly avoiding its obligation to repay funds received for COVID-19 testing of patients who had health insurance, the Justice Department announced.
Source: Washington Times | https://www.washingtontimes.com/rss/headlines/news/ - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



